Companies / S66

STAR COMBO PHARMA LIMITED

ASX:S66Household & Personal Products
135.1M shares on issueASX (delayed) · as of 28 July 2026$0.12price · delayed$16.2Mmarket cap · indicative
A
Dilution grade

No issuance filings since 2024; no dilution pressure signals in current disclosures

Cash runwayno data — not a quarterly (4C/5B) cash filer
Share-count growth (24m)0.0%no issuance filings since 2024
Raise cadence (24m)0 cash raises
Options & rights overhang0.0% of shares
In-the-money supply0.0% of shares
Pending proposed issuesnone

STAR COMBO PHARMA LIMITED has no share-issuance (Appendix 2A) filings on record in the window and no new share-issuance filings lodged since January 2024. There were no capital raises in the 24-month window. Options/rights data is not provided. The company does not have a current quarterly cash report on record, so no quarterly cash balance or funding-runway figure is disclosed. No proposed securities issues (Appendix 3B) are pending.

AI-generated summary of this page's cited filings · updated 28 July 2026
Email me when this grade changes
Alerts are coming soon — this opens a pre-filled email that puts you on the list.
0.0%
Max option dilution
0.0%
ITM option dilution
0
Raises · last 12 months
—
Cash cover · not a quarterly filer

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 135.1M per ASX (delayed) (28 July 2026).
134.5M135.1M135.6MDec 24Sept 25July 26

Cash runway

Not a quarterly cash filer. This company does not lodge Appendix 4C/5B quarterly cash reports, so cash runway does not apply.

Issuance timeline

Latest 0 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

No issuance filings (Appendix 2A / 3G / 3H) on record.
Paid plan
Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Join the waitlist

Capital raises

No equity raises in the last 24 months.
Paid plan
Full raise history
Issue price, discount, brokers, purpose and tranche detail for every raise on record.
Join the waitlist

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

No options or rights over unissued shares on record.

Director dealings

No director dealing notices (Appendix 3Y) on record.
Paid plan
Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Join the waitlist

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Sign up free — coming soon

Latest announcements

25 Feb 2026$PS66 Dec 25 Half Year Report and Financial Statements
25 Nov 2025S66 - Resuts of Voting at 2025 AGM
24 Nov 2025S66 CEO Presentation to 2025 AGM
23 Oct 2025S66 2025 ASX Appendix 4G
23 Oct 2025S66 2025 Corporate Governance Statement
23 Oct 2025S66 2025 AGM - NOM / EM / Proxy
23 Oct 2025S66 2025 Annual Report
9 Oct 2025S66 Date of 2025 AGM
26 Aug 2025Dividend/Distribution - S66
26 Aug 2025$PS66 FYE June 2025 Results Announcement
26 Aug 2025$PS66 Preliminary Final Report
15 Apr 2025$PS66 Insurance Claim Settlement
14 Apr 2025Details of Share Registry address
26 Feb 2025$PS66 Dec 2024 Half Year Report & Financial Statements
26 Nov 2024S66 - Results of Voting at 2024 AGM
25 Nov 2024S66 CEO Presentation to 2024 AGM
24 Oct 2024S66 Appendix 4G 2024
24 Oct 2024S66 Corporate Governance Statement 2024
24 Oct 2024S66 2024 AGM - NOM / EM / Proxy
24 Oct 2024S66 2024 Annual Report

Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 July 2026.